Medicare Enrolled
Dr. Bao Tran, M.D.
Cardiovascular Disease · San Francisco, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tran
Dr. Bao Tran is a cardiovascular disease specialist in San Francisco, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Tran performed 2,557 Medicare services across 1,618 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tran received a total of $108,100 from 76 pharmaceutical and/or device companies across 1458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 41% volume in CA
$108,100 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,557
Medicare services
Top 41% in CA for cardiovascular disease
1,618
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~150 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
546 | $109 | $300 |
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
427 | $0 | $2 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
200 | $14 | $70 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
139 | $70 | $200 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
138 | $7 | $100 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
93 | $190 | $750 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
78 | $155 | $400 |
| New patient office visit, complex (60-74 min) | 70 | $196 | $500 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
64 | $11 | $100 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
52 | $12 | $80 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
52 | $55 | $100 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
52 | $34 | $200 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
48 | $71 | $200 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
38 | $201 | $450 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
37 | $202 | $450 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
37 | $48 | $100 |
| Cardiac catheterization | 33 | $178 | $1,500 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
29 | $66 | $325 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
28 | $254 | $450 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $150 | $500 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
27 | $63 | $300 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
27 | $193 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $171 | $500 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
25 | $20 | $250 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
24 | $470 | $1,500 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
24 | $11 | $250 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
23 | $80 | $625 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
22 | $358 | $4,400 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
22 | $62 | $600 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
21 | $230 | $1,000 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $83 | $153 |
| Online digital evaluation for established patient, 5-10 minutes This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days. |
18 | $13 | $147 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
16 | $71 | $200 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
16 | $21 | $100 |
| Ultrasound of blood vessel, initial vessel An ultrasound exam of a blood vessel that includes a radiologist's review of the initial vessel. |
15 | $74 | $1,800 |
| Heart muscle strain imaging | 15 | $39 | $88 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
14 | $129 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
12 | $99 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
33.0% medium
61.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$108,100
Total received (2018-2024)
Avg $15,443/year across 7 years
Top 6% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
1,458
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$73,953 (68.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26,717 (24.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,430 (6.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$33,777
2023
$15,956
2022
$9,139
2021
$9,700
2020
$4,117
2019
$27,047
2018
$8,363
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lexicon Pharmaceuticals, Inc.
$20,822
Janssen Pharmaceuticals, Inc
$5,044
Recor Medical Inc
$1,683
Inari Medical, Inc.
$702
Boston Scientific Corporation
$609
Medtronic, Inc.
$496
E.R. Squibb & Sons, L.L.C.
$386
Abbott Laboratories
$341
Bayer Healthcare Pharmaceuticals Inc.
$332
Amgen Inc.
$306
Novartis Pharmaceuticals Corporation
$286
PFIZER INC.
$268
Boehringer Ingelheim Pharmaceuticals, Inc.
$265
Novo Nordisk Inc
$235
Actelion Pharmaceuticals US, Inc.
$198
AstraZeneca Pharmaceuticals LP
$195
CVRx, Inc.
$177
ABIOMED
$173
Merck Sharp & Dohme LLC
$170
Esperion Therapeutics, Inc.
$165
Kestra Medical Technology Services, Inc.
$158
Edwards Lifesciences Corporation
$101
iRhythm Technologies, Inc.
$100
Kiniksa Pharmaceuticals International, plc
$94
Seigla Medical, Inc.
$86
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$69
Alnylam Pharmaceuticals Inc.
$68
Philips North America LLC
$45
Baxter Healthcare
$39
Becton, Dickinson and Company
$38
ATRICURE, INC.
$37
Chiesi USA, Inc.
$35
SANOFI-AVENTIS U.S. LLC
$32
HEARTFLOW, INC.
$22
Top 3 companies account for 81.6% of 2024 payments
All-time payments by company (2018-2024) ›
Lexicon Pharmaceuticals, Inc.
$21,022
Abbott Laboratories
$14,478
Medtronic, Inc.
$11,050
Medtronic Vascular, Inc.
$10,874
Janssen Pharmaceuticals, Inc
$7,541
Boston Scientific Corporation
$5,979
CathWorks, Inc.
$3,515
Amgen Inc.
$2,431
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,374
AstraZeneca Pharmaceuticals LP
$2,297
Novartis Pharmaceuticals Corporation
$2,252
Penumbra, Inc.
$1,964
Recor Medical Inc
$1,683
Cardiovascular Systems Inc.
$1,645
SANOFI-AVENTIS U.S. LLC
$1,500
E.R. Squibb & Sons, L.L.C.
$1,333
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,141
Novo Nordisk Inc
$1,114
Esperion Therapeutics, Inc.
$990
Becton, Dickinson and Company
$888
Inari Medical, Inc.
$860
Actelion Pharmaceuticals US, Inc.
$860
PFIZER INC.
$726
Impulse Dynamics (USA) Inc.
$692
BOSTON SCIENTIFIC CORPORATION
$644
Amarin Pharma Inc.
$641
Merck Sharp & Dohme LLC
$628
Chiesi USA, Inc.
$534
Bardy Diagnostics, Inc.
$460
ShockWave Medical, Inc
$444
Vertex Pharmaceuticals Incorporated
$413
Edwards Lifesciences Corporation
$399
iRhythm Technologies, Inc.
$390
Bayer HealthCare Pharmaceuticals Inc.
$382
Bayer Healthcare Pharmaceuticals Inc.
$366
BIOTRONIK INC.
$362
Shockwave Medical, Inc
$353
ABIOMED
$351
CVRx, Inc.
$177
Kestra Medical Technology Services, Inc.
$158
Kiniksa Pharmaceuticals, Ltd.
$144
Relypsa, Inc.
$137
Incyte Corporation
$133
SCPHARMACEUTICALS INC.
$112
United Therapeutics Corporation
$112
Lundbeck LLC
$111
Janssen Scientific Affairs, LLC
$100
Astellas Pharma US Inc
$97
Kiniksa Pharmaceuticals International, plc
$94
Kowa Pharmaceuticals America, Inc.
$93
Alnylam Pharmaceuticals Inc.
$90
Merck Sharp & Dohme Corporation
$90
Seigla Medical, Inc.
$86
ARBOR PHARMACEUTICALS, INC.
$62
HeartFlow, Inc.
$61
Gilead Sciences, Inc.
$58
CHIESI USA, INC.
$56
Itamar Medical Inc
$56
Regeneron Healthcare Solutions, Inc.
$45
Philips North America LLC
$45
Baxter Healthcare
$39
AngioDynamics, Inc.
$38
ATRICURE, INC.
$37
Aziyo Biologics, Inc.
$27
Osprey Medical Inc
$25
Almirall LLC
$25
Avinger Inc.
$25
Philips Electronics North America Corporation
$24
Terumo Medical Corporation
$23
Arbor Pharmaceuticals, Inc.
$23
ASAHI INTECC USA, INC.
$23
HEARTFLOW, INC.
$22
Braemar Manufacturing, LLC
$21
Teva Pharmaceuticals USA, Inc.
$21
Sandoz Inc.
$19
Tactile Systems Technology Inc
$16
Top 3 companies account for 43.1% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AJOVY · AMVUTTRA · ASAHI PTCA Guide Wire · ASSURITY · AVVIGO · AVVIGO Guidance System · Adempas · AngioVac · Arcalyst · Asahi Fielder coronary guide wire · Assure WCD · Azure · BIOMONITOR · BOSENTAN TABLETS · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CLEVIPREX · COMET · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · ClosureFast · Comet · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · Diamondback Peripheral · DxTerity · DyeVert · ECM Patch · EKOSONIC · ELIQUIS · ELUVIA · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EPIC VASCULAR · EVEREST · EXPORT AP · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EkoSonic · Endurant · Expo · FARXIGA · FFRangio · FFRangio System · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · FilterWire EZ · Flexitouch Plus · Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter · GENERAL ATHERECTOMY · GENERAL THERAPIES · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL THROMBECTOMY · GENERAL VASCULAR ACCESS · GENERAL VASCULAR INTERVENTION · GENERAL - ATHERECTOMY · GENERAL - BALLOONS · GENERAL - THROMBECTOMY · General - Stents · General - Therapies · General - Vascular Access · General - Vascular Intervention · HawkOne · HeartMate 3 Left Ventricular Dev · Heartrail · I-STAT · ILAB · IN.PACT Admiral · INVOKANA · Impella · Indigo · Indigo System · Inpefa · JAKAFI · JARDIANCE · JETSTREAM · JETSTREAM SC · JOT DX · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LifeVest · Livalo · MAMBA · MULTAQ · Mitra Clip system · NEXLETOL · NEXLIZET · NORTHERA · OMNILINK ELITE · ONYX FRONTIER · OPSUMIT · OPTICROSS · OPTIMIZER · Omnilink Elite vascular stent system · OptiCross · Optimizer · Ozempic · PANTHERIS · PARADISE RENAL DENERVATION SYSTEM · PERCLOSE PROGLIDE · PERCLOT · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra Ruby Coil · Penumbra System · Peripheral Orbital Atherectomy System · Pouch · QT Vascular Chocolate PTA Balloon · RESOLUTE ONYX · ROTAPRO · RYBELSUS · Ranger · Repatha · Resolute · Reveal LINQ · Rybelsus · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · TELESCOPE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TREPROSTINIL · Telescope · UPTRAVI · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · Veltassa · VenaSeal · Venclose Maven Catheter · Verquvo · Viance · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPATONE · XARELTO · Xience V coronary stent system · Xolegel · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
204
Per 100K population
24.4
County median income
$141,446
Nearest hospital
CALIFORNIA PACIFIC MEDICAL CTR-DAVIES CAMPUS HOSP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tran is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 6% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tran experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tran performed 546 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $108,100 from 76 companies across 1,458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other cardiologists in San Francisco?
Dr. Tran's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Francisco
Browse cardiologists in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Lexicon Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Lexicon Pharmaceuticals, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology